151st Meeting of the National Advisory Council on Drug Abuse
Hybrid Meeting – September 9, 2025
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.
C. Appendix 2).
| Time | Presentation |
|---|---|
| 10:30 a.m. | Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA |
| 10:45 a.m. | Council Review of Grant Applications Office of Translational Initiatives and Program Innovations (OTIPI) Division of Therapeutics and Medical Consequences (DTMC) Division of Neuroscience and Behavior (DNB) Division of Epidemiology, Services, and Prevention Research (DESPR) Office of Research Training and Career Development (ORTCD) |
| 11:45 p.m. | Break |
Videocast:
Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Gillian Acca, within ten days of the meeting. Any written statements by members of the public will receive careful consideration.
Join the Videocast.
Open Session
| Time | Presentation |
|---|---|
| 1:00 p.m. | Welcome and Opening Remarks Nora Volkow, M.D., Director, NIDA |
| 1:15 p.m. | Director's Report Nora Volkow, M.D., Director, NIDA |
| 2:00 p.m. | Discussion Council Members |
| 2:30 p.m. | The NIH HEAL Initiative: Progress and Promise Michele Rankin, Ph.D. Director, NIDA HEAL Initiative Research Program |
| 3:00 p.m. | Break |
| 3:15 p.m. | ABCD: Continuing the Arc of Development Gaya Dowling, Ph.D. Director, ABCD Program |
| 3:45 p.m. | Concept Clearances NIDA Staff |
| 4:15 p.m. | Public Comments |
| 4:30 p.m. | Adjourn |